Anliang Xia

机构：Anhui University, Anhui Medical University, First Affiliated Hospital of Anhui Medical University · ORCID：0000-0002-9459-0886

发表论文 25 篇 · 总被引 1508 次 · h-index 17

代表论文

• T Cell Dysfunction in Cancer Immunity and Immunotherapy (2019 · Frontiers in Immunology · 被引 346)
• TOX promotes the exhaustion of antitumor CD8+ T cells by preventing PD1 degradation in hepatocellular carcinoma (2019 · Journal of Hepatology · 被引 293)
• The cancer-testis lncRNA lnc-CTHCC promotes hepatocellular carcinogenesis by binding hnRNP K and activating YAP1 transcription (2022 · Nature Cancer · 被引 144)
• Chimeric-antigen receptor T (CAR-T) cell therapy for solid tumors: challenges and opportunities (2017 · Oncotarget · 被引 134)
• Retracted: Exosomes derived from exhausted CD8+ T cells impaired the anticancer function of normal CD8+ T cells (2018 · Journal of Medical Genetics · 被引 81)
• APAF1‐Binding Long Noncoding RNA Promotes Tumor Growth and Multidrug Resistance in Gastric Cancer by Blocking Apoptosome Assembly (2022 · Advanced Science · 被引 80)